Ovarian Cancer Recurrence Complicated by a Benign Surgical Stitch Reaction

This ovarian cancer diagnosis at a glance

Stage at diagnosis
Stage III
Sex
female
Treatment
surgery and chemotherapy
Outcome
Setback / Progression

Treatment course, step by step

  1. She received 3 cycles of carboplatin and paclitaxel chemotherapy before interval debulking surgery, followed by 3 more cycles of carboplatin and paclitaxel.
  2. About 8 months later, evaluation for suspected recurrence led to surgery.
  3. The scan-positive subdiaphragmatic lesion was a benign suture granuloma, but diffuse peritoneal relapse was found elsewhere.
  4. She then received second-line carboplatin and Caelyx and later moved to third-line chemotherapy for persistent disease.

What happened, in summary

A 44-year-old woman was diagnosed with Stage III papillary ovarian cancer after evaluation for ovarian masses, ascites, and extensive peritoneal disease. Because the cancer was too widespread for immediate tumor-reduction surgery, she first received 3 cycles of carboplatin and paclitaxel chemotherapy. After a partial response, she underwent interval debulking surgery and then completed 3 more cycles of the same chemotherapy.

Follow-up was negative for about 8 months before her CA125 level rose. CT and PET/CT scans showed a suspicious area beneath the right diaphragm that appeared to be an isolated recurrence. Surgery was planned, but biopsy showed that this particular lesion was actually an inflammatory granuloma caused by a nonabsorbable surgical stitch from the earlier operation.

At the same procedure, however, surgeons unexpectedly found diffuse peritoneal cancer recurrence elsewhere in the abdomen that had not been clearly detected on imaging. After surgery, she received second-line carboplatin and Caelyx and later moved to a third line of chemotherapy. At the latest report, persistent disease remained. Her case illustrates how postoperative inflammation can mimic cancer on scans while small-volume recurrent disease may still be missed.

Where this story comes from

This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full

How we source and attribute stories Accuracy and limitations

Collections this story belongs to

Similar ovarian cancer stories

These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer

Search more ovarian cancer stories